Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea participants with co-morbid insomnia: A randomized clinical trial.
Insomnia and obstructive sleep apnea (OSA) commonly co-occur which makes OSA difficult to treat with continuous positive airway pressure (CPAP). We conducted a randomized controlled trial in participants with OSA and co-occurring insomnia to test the hypothesis that initial treatment with cognitive and behavioral therapy for insomnia (CBT-i), versus treatment as usual (TAU) would improve insomnia symptoms and increase subsequent acceptance and use of CPAP. 145 participants with OSA (apnea-hypopnea index ≥ 15) and co-morbid insomnia were randomized to either 4 sessions of CBT-i, or TAU, before commencing CPAP therapy until 6-months post-randomization. Primary between-group outcomes included objective average CPAP adherence and changes in objective sleep efficiency by 6-months. Secondary between-group outcomes included rates of immediate CPAP acceptance/rejection, and changes in; sleep parameters, insomnia severity, and daytime impairments by 6-months. Compared to TAU, participants in the CBT-i group had 61-minutes greater average nightly adherence to CPAP (95%CI: 9, 113; p = 0.023, d = 0.38) and higher initial CPAP treatment acceptance (99 vs 89%; p = 0.034). The CBT-i group showed greater improvement of global insomnia severity, and dysfunctional sleep-related cognitions by 6-months (both: p < 0.001), and greater improvement in sleep impairment measures immediately following CBT-i. There were no between-group differences in sleep outcomes, or daytime impairments by 6-months. In OSA participants with co-morbid insomnia, CBT-i prior to initiating CPAP treatment improves CPAP use and insomnia symptoms compared to commencing CPAP without CBT-i. OSA patients should be evaluated for co-occurring insomnia and considered for CBT-i before commencing CPAP therapy.